
Beginning on Thursday morning, Anthropic’s stock goes up for sale, and the public will be able to invest in “the responsible development and maintenance of AI for the long-term benefit of humanity.” Since Anthropic is a public-benefit company, it is required to disclose risks and to explain how its goals for benefitting the public may affect shareholder profits. Most of its S-1 filing concerns the prospects for profit, on the back of the promise that, “if managed well,” A.I. “could rapidly accelerate scientific innovation, greatly increase economic growth rates, bring cures for major diseases within reach, and solve problems that have resisted generations of human effort.” But the company also acknowledges that its technology “may pose catastrophic or existential risks to humanity” and that, even if Claude doesn’t kill everyone, public concern that it might “could adversely affect our reputation and brand.” Jill Lepore analyzes the A.I. company’s stock prospectus: newyorkermag.visitlink.me/qH…


























